magnolol has been researched along with Pulmonary Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HY; Chen, MC; Chen, TH; Chou, TC; Lin, MH | 1 |
| Huang, MS; Lee, CH; Shih, HC | 1 |
2 other study(ies) available for magnolol and Pulmonary Edema
| Article | Year |
|---|---|
Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-γ-dependent inhibition of NF-kB activation.
Topics: Acute Lung Injury; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Bronchoalveolar Lavage Fluid; Cytokines; Lignans; Lipopolysaccharides; Male; Neutrophil Infiltration; NF-kappa B; Oxidative Stress; Peroxidase; PPAR gamma; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2015 |
Magnolol attenuates the lung injury in hypertonic saline treatment from mesenteric ischemia reperfusion through diminishing iNOS.
Topics: Animals; Antioxidants; Biphenyl Compounds; Interleukin-6; Lignans; Lung; Male; Mesentery; Mice; Mice, Inbred C3H; Models, Animal; Nitric Oxide Synthase Type II; Peroxides; Peroxynitrous Acid; Pulmonary Edema; Regional Blood Flow; Reperfusion Injury; Saline Solution, Hypertonic; Tumor Necrosis Factor-alpha | 2012 |